S 4332
Medication Competition Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 7:35 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The Medication Competition Act aims to speed up the availability of lower-cost generic versions of biological drugs. It directs the Secretary of Health and Human Services to establish a process for determining how long a new, generic version of a biological drug can be sold without competition from the original brand-name drug. Specifically, the bill clarifies and streamlines the process for identifying and publishing exclusivity periods for licensed biological products, ensuring quicker access to competition.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.